MAPT and early-onset autosomal dominant Alzheimer disease: To further examine the relationship between OCRL and Alzheimer’s disease pathology, we performed double immunofluorescence staining for phosphorylated tau (pTau, using the AT8 antibody) and OCRL (Figure 2).